NEPH - Nephros, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Nephros, Inc.

380 Lackawanna Place
South Orange, NJ 07079
United States
201-343-5202
http://www.nephros.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees18

Key Executives

NameTitlePayExercisedYear Born
Mr. Daron G. EvansPres, CEO & Director380.19kN/A1974
Mr. Andrew AstorCFO & COO288.37kN/A1957
Ms. Joleen C. TurnerVP of Marketing & Bus. Devel.N/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Nephros, Inc., a commercial stage medical device and commercial product company, develops and sells liquid purification filters and hemodiafiltration (HDF) systems primarily in the United States. It operates through two segments, Water Filtration and Renal Products. The company's ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from water borne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It offers HDF systems for use in conjunction with a hemodialysis machine that enables nephrologists to provide HDF treatment to patients with end stage renal disease; hemodiafilters for use as dialyzers in hemodialysis treatment; and water filters to food service, hospitality, and convenience store markets under the AETHER brand name. The company was founded in 1997 and is headquartered in South Orange, New Jersey.

Corporate Governance

Nephros, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.